Patents by Inventor Jack Bevers, III

Jack Bevers, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240092887
    Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of making and using the same, e.g., for treatment of IL-33 mediated disorders (e.g., ocular disorders such as AMD (e.g., geographic atrophy (GA)).
    Type: Application
    Filed: August 2, 2023
    Publication date: March 21, 2024
    Inventors: Gerald R. NAKAMURA, Dhaya SESHASAYEE, Menno VAN LOOKEREN CAMPAGNE, Tiffany WONG, Jia WU, Hongkang XI, Jack BEVERS, III, Hiu Nam CHAN, Laetitia COMPS-AGRAR, Racquel CORPUZ
  • Patent number: 11760797
    Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of making and using the same, e.g., for treatment of IL-33 mediated disorders (e.g., ocular disorders such as AMD (e.g., geographic atrophy (GA)).
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: September 19, 2023
    Assignee: Genentech, Inc.
    Inventors: Gerald R. Nakamura, Dhaya Seshasayee, Menno Van Lookeren Campagne, Tiffany Wong, Jia Wu, Hongkang Xi, Jack Bevers, III, Hiu Nam Chan, Laetitia Comps-Agrar, Racquel Corpuz
  • Patent number: 11725050
    Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.
    Type: Grant
    Filed: June 16, 2020
    Date of Patent: August 15, 2023
    Assignee: Genentech, Inc.
    Inventors: Philip E. Hass, Meredith Hazen, Yi-Chun Hsiao, Rajita Khosla, Gerald R. Nakamura, Dhaya Seshasayee, Menno Van Lookeren Campagne, Hongkang Xi, Wenwu Zhai, Jack Bevers, III, Nancy Chiang
  • Patent number: 11555076
    Abstract: The invention provides anti-MIC antibodies and methods of using the same.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: January 17, 2023
    Assignee: Genentech, Inc.
    Inventors: Twyla Noelle Lombana, Christoph Spiess, Jeong Kim, Evangeline Toy, Jill Schartner, Zhengmao Ye, Jack Bevers, III, Ryan Cook, Marissa Matsumoto, Amy Berkley
  • Publication number: 20210284725
    Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of making and using the same, e.g., for treatment of IL-33 mediated disorders (e.g., ocular disorders such as AMD (e.g., geographic atrophy (GA)).
    Type: Application
    Filed: March 12, 2021
    Publication date: September 16, 2021
    Inventors: Gerald R. NAKAMURA, Dhaya SESHASAYEE, Menno VAN LOOKEREN CAMPAGNE, Tiffany WONG, Jiansheng WU, Hongkang XI, Jack BEVERS, III, Joyce CHAN, Laetitia COMPS-AGRAR, Racquel CORPUZ
  • Publication number: 20210009705
    Abstract: The invention provides anti-OX40 antibodies and methods of using the same.
    Type: Application
    Filed: June 24, 2020
    Publication date: January 14, 2021
    Applicant: Genentech, Inc.
    Inventors: Changchun DU, Jeong KIM, Jing ZHU, Jack BEVERS, III, Kevin WALSH, Patricia DE ALMEIDA, James ANDYA, Ye SHEN
  • Publication number: 20210002361
    Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.
    Type: Application
    Filed: June 16, 2020
    Publication date: January 7, 2021
    Inventors: Philip E. HASS, Meredith HAZEN, Yi-Chun HSIAO, Rajita KHOSLA, Gerald R. NAKAMURA, Dhaya SESHASAYEE, Menno VAN LOOKEREN CAMPAGNE, Hongkang XI, Wenwu ZHAI, Jack BEVERS, III, Nancy CHIANG
  • Patent number: 10730951
    Abstract: The invention provides anti-OX40 antibodies and methods of using the same.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: August 4, 2020
    Assignee: Genentech, Inc.
    Inventors: Changchun Du, Jeong Kim, Jing Zhu, Jack Bevers, III, Kevin Walsh, Patricia De Almeida, James Andya, Ye Shen
  • Patent number: 10723795
    Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: July 28, 2020
    Assignee: Genentech, Inc.
    Inventors: Philip E. Hass, Meredith Hazen, Yi-Chun Hsiao, Rajita Khosla, Gerald R. Nakamura, Dhaya Seshasayee, Menno Van Lookeren Campagne, Hongkang Xi, Wenwu Zhai, Jack Bevers, III, Nancy Chiang
  • Publication number: 20200055939
    Abstract: The invention provides anti-MIC antibodies and methods of using the same.
    Type: Application
    Filed: October 27, 2017
    Publication date: February 20, 2020
    Applicant: Genentech, Inc.
    Inventors: Twyla Noelle LOMBANA, Christoph SPIESS, Jeong KIM, Evangeline TOY, Jill SCHARTNER, Zhengmao YE, Jack BEVERS, III, Ryan COOK, Marissa MATSUMOTO, Amy BERKLEY
  • Publication number: 20190092852
    Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.
    Type: Application
    Filed: August 31, 2018
    Publication date: March 28, 2019
    Inventors: Philip E. HASS, Meredith HAZEN, Yi-Chun HSIAO, Rajita KHOSLA, Gerald R. NAKAMURA, Dhaya SESHASAYEE, Menno VAN LOOKEREN CAMPAGNE, Hongkang XI, Wenwu ZHAI, Jack BEVERS, III, Nancy CHIANG
  • Publication number: 20190062444
    Abstract: The invention provides compositions and methods for treating cancers. The method comprises administering an anti-angiogenesis agent and an OX40 binding agonist.
    Type: Application
    Filed: June 28, 2018
    Publication date: February 28, 2019
    Applicant: Genentech, Inc.
    Inventors: Kevin Walsh, Patricia De Almeida, Changchun Du, Jeong Kim, Jing Zhu, Jack Bevers, III, James Andya, Ye Shen
  • Patent number: 10093730
    Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: October 9, 2018
    Assignee: Genentech, Inc.
    Inventors: Philip E. Hass, Meredith Hazen, Yi-Chun Hsiao, Rajita Khosla, Gerald R. Nakamura, Dhaya Seshasayee, Menno Van Lookeren Campagne, Hongkang Xi, Wenwu Zhai, Jack Bevers, III, Nancy Chiang
  • Publication number: 20180230227
    Abstract: The invention provides anti-OX40 antibodies and methods of using the same.
    Type: Application
    Filed: April 11, 2018
    Publication date: August 16, 2018
    Applicant: Genentech, Inc.
    Inventors: Changchun DU, Jeong KIM, Jing ZHU, Jack BEVERS, III, Kevin WALSH, Patricia DE ALMEIDA, James ANDYA, Ye SHEN
  • Patent number: 9975957
    Abstract: The invention provides anti-OX40 antibodies and methods of using the same.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: May 22, 2018
    Assignee: Genentech, Inc.
    Inventors: Changchun Du, Jeong Kim, Jing Zhu, Jack Bevers, III, Kevin Walsh, Patricia De Almeida, James Andya, Ye Shen
  • Publication number: 20170015755
    Abstract: The invention provides compositions and methods for treating cancers. The method comprises administering an anti-angiogenesis agent and an OX40 binding agonist.
    Type: Application
    Filed: September 29, 2016
    Publication date: January 19, 2017
    Applicant: Genentech, Inc.
    Inventors: Kevin WALSH, Patricia DE ALMEIDA, Changchun DU, Jeong KIM, Jing ZHU, Jack BEVERS, III, James ANDYA, Ye SHEN
  • Publication number: 20160168242
    Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.
    Type: Application
    Filed: November 10, 2015
    Publication date: June 16, 2016
    Inventors: Philip E. HASS, Meredith HAZEN, Yi-Chun HSIAO, Rajita KHOSLA, Gerald R. NAKAMURA, Dhaya SESHASAYEE, Menno VAN LOOKEREN CAMPAGNE, Hongkang XI, Wenwu ZHAI, Jack BEVERS, III, Nancy CHIANG
  • Publication number: 20150307617
    Abstract: The invention provides anti-OX40 antibodies and methods of using the same.
    Type: Application
    Filed: March 30, 2015
    Publication date: October 29, 2015
    Applicant: Genentech, Inc.
    Inventors: Changchun DU, Jeong Kim, Jing Zhu, Jack Bevers, III, Kevin Walsh, Patricia De Almeida, James Andya, Ye Shen